| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1996) |
| Entry Type: | Enzyme |
| Molecule Category: | UNKNOWN |
| ATC: | B01AD02 |
| UNII: | 1RXS4UE564 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ACTIVATOR | Plasminogen activator | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Thrombosis | 4 | D013927 | ClinicalTrials |
| Myocardial Infarction | 4 | D009203 | ClinicalTrials |
| Abscess | 3 | D000038 | ClinicalTrials |
| Empyema | 3 | D004653 | ClinicalTrials |
| Cerebral Hemorrhage | 3 | D002543 | ClinicalTrials |
| Hemorrhage | 3 | D006470 | ClinicalTrials |
| Subarachnoid Hemorrhage | 3 | D013345 | ClinicalTrials |
| Retinal Artery Occlusion | 3 | D015356 | ClinicalTrials |
| Empyema, Pleural | 3 | D016724 | ClinicalTrials |
| Myocardial Ischemia | 3 | D017202 | ClinicalTrials |
| Angina, Stable | 3 | D060050 | ClinicalTrials |
| Respiratory Distress Syndrome | 3 | D012128 | ClinicalTrials |
| Ischemic Stroke | 3 | D000083242 | ClinicalTrials |
| Cerebral Infarction | 3 | D002544 | ClinicalTrials |
| Brain Ischemia | 3 | D002545 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Nervous System Diseases | 2 | D009422 | ClinicalTrials |
| Venous Thrombosis | 2 | D020246 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Abdominal Abscess | 2 | D018784 | ClinicalTrials |
| Urinary Retention | 2 | D016055 | ClinicalTrials |
| Bronchitis | 2 | D001991 | ClinicalTrials |
| Retinal Vein Occlusion | 1 | D012170 | ClinicalTrials |
| Thrombophlebitis | 1 | D013924 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 105857-23-6 |
| ChEMBL | CHEMBL1201593 |
| FDA SRS | 1RXS4UE564 |
CONTENTS